Trump Says Imported Generic Drugs To Face 100% Tariff From August 2028
President Donald Trump announced a 100% tariff on imported generic medications scheduled to take effect in August 2028. The policy is designed to incentivize the relocation of pharmaceutical manufacturing to the United States.
President Donald Trump stated on Tuesday that the United States will impose 100% tariffs on imported generic drugs beginning in August 2028. The administration framed the decision as a strategic effort to decrease dependency on foreign suppliers and bolster the domestic pharmaceutical industry.
The announcement specifically targets generic medications, which make up a significant portion of the American drug supply chain. Officials indicated that the delayed implementation date is intended to provide pharmaceutical companies with enough time to establish or expand production facilities within U.S. borders.
Critics and industry experts are currently evaluating the potential impact of these tariffs on consumer healthcare costs and the stability of the pharmaceutical market. The administration maintains that onshoring production is a matter of national security and supply chain resilience. Source: US President Donald Trump announcement.
